Novartis AGNVS

Close of Friday, October 23, 2026 · Novartis AG is trading below its Pivot, OnlyAlpha's long-term trend line.

Price

$151.11

vs its Pivot

-0.2%

OnlyAlpha Score

Trend

Below its Pivot

Last 12 months. Solid line: price. Dashed green: the Pivot.

Returns

1 month	Year to date	1 year	3 years / yr	5 years / yr
+5.3%	+12.9%	+18.5%	+20.4%	+16.9%

Dividend: $4.77 a share over the last 12 months, a 3.16% yield at today's price. A Dividend Aristocrat.

Suppliers, customers and partners

Sells to NVS

Alnylam	Leqvio (inclisiran) via MDCO agreement
Incyte	Jakavi ex-US royalties
Royalty Pharma	Promacta, $142M
Genmab	Kesimpta 10% royalty
Arrowhead Pharmaceuticals	2025 global license

From the companies' own annual reports filed with the SEC.

Healthcare · Pharma

PRGO +28%ABBV +21%AMGN +18%AZN -5%BMY +3%GALDY +14%GILD +12%GSK -3%JNJ +7%LLY +17%MRK +15%NVO -13%

Get NVS in your free daily emailAfter every close: whether NVS is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track NVS free → Full Stock check